位置:首页 > 蛋白库 > AT325_ASPTN
AT325_ASPTN
ID   AT325_ASPTN             Reviewed;        3890 AA.
AC   Q0D159;
DT   15-FEB-2017, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 1.
DT   03-AUG-2022, entry version 104.
DE   RecName: Full=Hybrid PKS-NRPS synthetase ATEG_00325 {ECO:0000303|PubMed:21236704};
DE            EC=2.3.1.- {ECO:0000305|PubMed:21236704};
DE            EC=6.3.2.- {ECO:0000305|PubMed:21236704};
DE   AltName: Full=Isoflavipucine biosynthesis cluster protein ATEG_00325 {ECO:0000303|PubMed:21236704};
GN   ORFNames=ATEG_00325;
OS   Aspergillus terreus (strain NIH 2624 / FGSC A1156).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=341663;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NIH 2624 / FGSC A1156;
RA   Birren B.W., Lander E.S., Galagan J.E., Nusbaum C., Devon K., Henn M.,
RA   Ma L.-J., Jaffe D.B., Butler J., Alvarez P., Gnerre S., Grabherr M.,
RA   Kleber M., Mauceli E.W., Brockman W., Rounsley S., Young S.K., LaButti K.,
RA   Pushparaj V., DeCaprio D., Crawford M., Koehrsen M., Engels R.,
RA   Montgomery P., Pearson M., Howarth C., Larson L., Luoma S., White J.,
RA   Alvarado L., Kodira C.D., Zeng Q., Oleary S., Yandava C., Denning D.W.,
RA   Nierman W.C., Milne T., Madden K.;
RT   "Annotation of the Aspergillus terreus NIH2624 genome.";
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   IDENTIFICATION, FUNCTION, INDUCTION, DOMAIN, AND DISRUPTION PHENOTYPE.
RX   PubMed=21236704; DOI=10.1016/j.chembiol.2010.12.011;
RA   Gressler M., Zaehle C., Scherlach K., Hertweck C., Brock M.;
RT   "Multifactorial induction of an orphan PKS-NRPS gene cluster in Aspergillus
RT   terreus.";
RL   Chem. Biol. 18:198-209(2011).
CC   -!- FUNCTION: PKS-NRPS hybrid synthetase; part of the gene cluster that
CC       mediates the biosynthesis of isoflavipucine (PubMed:21236704). The PKS
CC       part of the PKS-NRPS ATEG_00325 probably assembles a triketide from an
CC       acetyl starter and two malonyl-CoA extender units (PubMed:21236704).
CC       The poly-beta-keto intermediate would then be fused to the leucine unit
CC       by the NRPS part (PubMed:21236704). The resulting amide would be
CC       liberated from the PKS-NRPS through reductive release of the linear
CC       PKS-NRPS product from the enzyme complex (PubMed:21236704). Further
CC       steps in isoflapucine synthesis include a cyclization step, an
CC       oxidation step, a hydrolysis step involving a trans-amidation, and an
CC       additional oxidation step, leading to flavipucine (PubMed:21236704).
CC       Formation of isoflavipucine from flavipucine requires an unusual
CC       rearrangement (PubMed:21236704). Alternative rearrangement reactions
CC       could build up rubrobramide, representing a branching of flavipucine
CC       biosynthesis (PubMed:21236704). The enzymes involved in the post-PKS-
CC       NRPS steps have not been identified yet, but the putative oxygenases
CC       ATEG_003329 and ATEG_00330 encoded by the cluster could play a role
CC       (PubMed:21236704). {ECO:0000269|PubMed:21236704}.
CC   -!- INDUCTION: Expression is inhibited by various sugars, including
CC       glucose, fructose, mannose, and ribose (PubMed:21236704). Expression is
CC       repressed by the carbon catabolite repressor creA (PubMed:21236704).
CC       Expression is increased at alkaline pH in a pacC dependent manner, but
CC       glucose repression dominates the effect of alkalization
CC       (PubMed:21236704). Nitrogen sources such as amino acids Asn or Gln can
CC       also activate expression (PubMed:21236704). Finally, expression is
CC       positively controled by the cluster-specific regulator ATEG_00326
CC       (PubMed:21236704). {ECO:0000269|PubMed:21236704}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module (PubMed:21236704). Each module is responsible for the
CC       recognition (via the A domain) and incorporation of a single amino acid
CC       into the growing peptide product (PubMed:21236704). Thus, an NRP
CC       synthetase is generally composed of one or more modules and can
CC       terminate in a thioesterase domain (TE) or reductase domain (R) that
CC       releases the newly synthesized peptide from the enzyme
CC       (PubMed:21236704). ATEG_00325 contains also a ketoacyl synthase domain
CC       (KS), an acyl transferase domain (AT), a dehydratase domain (DH), a
CC       methyltransferase (MT) domain, a ketoreductase domains (KR), and an
CC       acyl carrier (ACP) domain (PubMed:21236704). ATEG_00325 has the
CC       following architecture: KS-AT-DH-MT-KR-ACP-C-A-T-R/C (PubMed:21236704).
CC       The DH, MT and KR domains seem not to contribute to biosynthesis
CC       (PubMed:21236704). {ECO:0000269|PubMed:21236704}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes the production of isoflavipucine and
CC       dihydroisoflavipucine (PubMed:21236704). {ECO:0000269|PubMed:21236704}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the NRP synthetase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH476594; EAU38971.1; -; Genomic_DNA.
DR   RefSeq; XP_001210411.1; XM_001210411.1.
DR   SMR; Q0D159; -.
DR   STRING; 33178.CADATEAP00006020; -.
DR   EnsemblFungi; EAU38971; EAU38971; ATEG_00325.
DR   GeneID; 4355077; -.
DR   VEuPathDB; FungiDB:ATEG_00325; -.
DR   eggNOG; KOG1178; Eukaryota.
DR   eggNOG; KOG1202; Eukaryota.
DR   HOGENOM; CLU_000022_37_5_1; -.
DR   OMA; GYPPISE; -.
DR   OrthoDB; 19161at2759; -.
DR   Proteomes; UP000007963; Unassembled WGS sequence.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 2.
DR   Gene3D; 3.10.129.110; -; 1.
DR   Gene3D; 3.30.300.30; -; 1.
DR   Gene3D; 3.30.559.10; -; 1.
DR   Gene3D; 3.40.366.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR013120; Far_NAD-bd.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR032821; PKS_assoc.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF00668; Condensation; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF07993; NAD_binding_4; 1.
DR   Pfam; PF00550; PP-binding; 2.
DR   Pfam; PF14765; PS-DH; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 2.
DR   SUPFAM; SSF47336; SSF47336; 2.
DR   SUPFAM; SSF51735; SSF51735; 2.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR   PROSITE; PS50075; CARRIER; 2.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE   2: Evidence at transcript level;
KW   Isomerase; Ligase; Phosphopantetheine; Phosphoprotein; Reference proteome;
KW   Repeat; Transferase.
FT   CHAIN           1..3890
FT                   /note="Hybrid PKS-NRPS synthetase ATEG_00325"
FT                   /id="PRO_0000438997"
FT   DOMAIN          2299..2377
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          3457..3536
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          7..441
FT                   /note="Ketosynthase (KS) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          552..857
FT                   /note="Malonyl-CoA:ACP transacylase (MAT) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          942..1105
FT                   /note="Dehydratase (DH) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          1341..1535
FT                   /note="Methyltransferase (MT) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          2058..2201
FT                   /note="Ketoreductase (KR) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          2271..2292
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2427..2449
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2474..2904
FT                   /note="Condensation (C) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          2938..3337
FT                   /note="Adenylation (A) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          3574..3803
FT                   /note="Reductase (R) domain"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        2274..2292
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   MOD_RES         2337
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3496
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   3890 AA;  422881 MW;  0453C45205A2B9BB CRC64;
     MSSNEPIAII GSSCRFAGGA SSPSKLWDLL LKPKDLSKPP PESRFNLEGF YHPNAEQHGN
     TNIHGSYFLE EDPRCFDTVF FNISPKEAEA IDPQQRILLE VVYEAMEAAG LTLQGLQGSD
     TSVYAGLMIR DYMDVQVRDP DFFSQYMVTG TSSALNANRI SYFFDWHGPS LTVDTACSSS
     LVAVHQAVQG LRAGESRVAC VTGSNLLLGP ELFISASNMH MLSSRSKMWD VSAEGYARGD
     GFASFMLKTL SNAIADGDHI EAIIRETGVN SDGRTKGITL PSPQAQADLI RDTYRRAGLD
     LSNPNDRCQY FEAHGTGTQA GDPREASAIH DAFFGAEGDD NKTGPKLVVG SIKTIVGHTE
     GTAGMAGMLK ALLAIRHRVI PPNLHFNNLN PSVAPFYDRL TVPTESIPWP VVAPGTPLRA
     SVNSFGFGGT NAHAIVESYE PDNRSSITGQ NDGIVLPLVL SAHSDKALAS VVENYAAFLR
     QTQQTLCLRD LAWTLHSRRS NLPVKAAFSG LSASDIAQQM QDRLESVRNT PGTELGIRSP
     AIASKKPSLL GVFTGQGAQW PTMGKHLIEN SRTFRETIER LEKSLSELDD GPDWSLKGEI
     LAQKAQSRVA EAALSQPLCT AIAIALVDLL HASGVSFTAV VGHSSGEIGA AYAAGVVTAE
     EAMKIAYYRG KYAKLAKGEH GAKGGMLAVG MGFNEAKEFC DQPAFKSRLG VAASNSPTSV
     TLSGDLDVVR EAKELLDARK TFARMLQVDT AYHSHHMLPC ADPYVSSLNA SRIQPNEPAK
     SSCSWISSVY GSEGDPTAEE LSATYWRDNM AQAVLFSQAL ERAMIECGPF DAVLEVGPHP
     ALKGPASQTL RELSDGPLPY FGVLDRKRND VVAFGDALAS LWLHFGPSAV DFEGYAAASG
     PEDLPPPKLV KDLPAYPWDH SQIYWRESRL SREFRTRASP PHELLGHPLP AGSSEDGLRW
     RNILRIEEVP WIGDHRFQGQ ALLPTSAFCS MAVDAALKLA AGSVDPVADG IELHDLVIHN
     AVSIPDGSQG VEIITSIQRL EVTNHPLDAE VTVLFGPPDG SKVLKKAASA RVILLHANSV
     DEPATLQARE KNLSSIDVPQ FYQSIALVEG CIQTAYAAFS APGDASLRPV FLPQKIERMS
     LRLPSVSSSD SWLIIDSFVT GVEKATPNTS PAFHADIEVA DSVSGKLLVE IEGVTISSFS
     PTSAADDREL FLQTVWKPVV SEGLSVGNEQ RKVANQAALD MEHQSILYLE NLLANNLYLS
     GHLSQEFEWL LQLNLPSHSK GRQHNDGAED VSHLDDFETL RAVAKNLPEL IRGRLPGADI
     ERQLQAFVET NSVFTRIKVG LHTLIDQIAH RFAHLNVLEI APAHLSPSFD AFNDLVESIS
     SYTLVTNSPS KDVAKYGKKL KHIGVEALHS DPSAIASALS GQKHDVVIAS YLLNGQTASF
     SEEALRQFRK VLKAGGYLVL VEPTQEYVWS RIFLGVLLGS ASNSDHGRDI GHHVSSVSLD
     GLLRKVGFSG IDSLLPRDAN GPGDAISLFV TQALDETIDL LRHPLQPSAL GILDGRRVLV
     VGGKTLQTSR LWHNIASILR PWTKEVHCIE SFEALEEKDS TGIAGAIVLT DLDEPASKLL
     TTKSYQAISG LFAQAPHVLW VTQGALEANP EQAASIGLGH FLAQEHSSVH SQFLNLDTVE
     ESEYKILGSF MRLLIPGIHD PQESRLWTTE TEISVKNGRV FIPRVFPARG LNDRLNSHWR
     PIIQSANTLN DTTSLSASGS LHAATFTAQH FSSSSSAERR PILRTTQSIP IAINVSNGIY
     LYLSAGQVDD VGDVLAFTDT MSSRAPALAT WKVPPAESGP VELSNILELT ANVLVAQHIF
     DSLPAGNSVL LEPSYTLATI INELTKGADK KVHFLTTAAR EETGSVTWTT IPPLASKRHI
     LSALPPCPKL FFDLSPKPNR LSSRIVSLLP VDCALVGPGE LFQLSSEGAE EVSTPWLQHV
     LLTVASSAVK LSRKATYPSS STLILSDLLE HGIRNANAVT VVDWTQQTSV PVTVEPLEPS
     QFLSPAGTYV LIDIEQPLIQ SIADWLIANG VRSLVAINSD IGERNGRELL DELKVKRLKV
     DLANLHDVKD VFDGLTKVTG VIYGGASAAM ANFGEDDAPL QTLQNVEQSA HNLTTILENQ
     EVGFFIILSS LQKDRAPVNA YFTSLAAHWK QRRLPTAVLS LESQVHSDPE GPFTHLSESD
     VHYALTEAIS SAQSQNDVSA IWTGVKRLPR DIPASSQWSW LSKPLFAHYT QREQEAEPGS
     SQGEAQSMVQ RLAASKSHEE ASLVIQEFFL TRLAVMLTLS QESLSSSNDL TSLGVDSLSA
     SDIRAWFLKE LDVDVSILKI LGGSTIADLC NEVAAGLTLQ IGSQEEAESQ PAVNSPEPVT
     AAPVPEQPTV ERHVESQEPV VEAAVVASSS DSSSEGTMTP PSSRGINTPH TEITNLQLES
     VKSKACTAVQ RREKMSFSQN RLWFPSAYLE QETPFNCTTS YTLTGPLDTA RLENAFQRLI
     QRHESFRTAF YTDEVSGAAM QRVLASSPFQ LRTMLGNKDD MQRVFRQIAN YHFDLSVADT
     LVATLISHGP KDHTIVFGYH HIIMDGVSWQ ITLNDLARFY ESDNPELPQL SQYIEFSVKQ
     RQLVSSGAHD AKLSYWRKEF PSAPPLLPLF PFAKVGARKA LTRYDTLDYI YDVDVSLVSK
     IKKASLAAKT TTFHFYLAAF VVLLNRFLEI DDVCLGIIDA NRSDKTFLNT VGFLLDMLPL
     RLKVNKKERF VHTLRNTRAK AYNALEHSGV PLETILKELQ VPTSATNTPL FQVLMNYRMG
     ALRAPQMGDA KMNFLDYEDA KAPFDLAISI DEKDDGTGML TFSMQDYMYD WEGAELLVKT
     YVHLLDTLAT DSSQRINEVS LFDESLVNQS MVAGTGPVTG LDWAGTETIS QRVDAMTAQR
     PDGVAVKDLN GKARTYAETQ ARVYALASSL QQAGITSGAR VAVYCEPTVD TVALVLAIYR
     VGAAYIPLDV RNSHERLADV VRECKPTLIL YHGATKHTLV DVAGDGQDAL DIDTVPQSAA
     PIPDVSKLSD PAVILYTSGS TGKPKGIMLT HANLSLQFAS ISSALDLTDR DVVLQQSALG
     FDASLSQMFM ALTNGGTLIH GSNRGDPVDL AALIEREGVT LTLIMISEMS ALLQYGSDIL
     SRCQSWRIAL CGGEAFTVNL LRKFRDLNLP NLELYNAYGP TEASIMSSLG KVAYRRTDWG
     DGSVVPVGPP LPNYGVYVLD ENFQPCPLGW PGELCICGPG VAEGYVGLPE LTSSKFQPDQ
     LRKPQGPSYD GWVRVYRTGD KARLLQDGSF VFLGRMDGDS QVKLRGIRIE LNDISNSIVK
     TSKEAIVDAA TIVKGTTSQT LVSFVVFAPA KVVDLERSNS SASAYLRQVI QSLPLPVYMR
     PAIAVPLERL PFTERGKLDT KALAAIPIQE DEETVNEELS ETEQKLKQVW QDILSEQGMS
     LEIRRQSDFF SVGGNSLMLM RVRAKMLEVF GVSVPLAELF QASTLETLAS RLDGNKTAES
     DNIVWNEETA LDVSLPPAIA HPRDHPEKDL SVILTGSTGF LGRAIVRQLI ADPRISTIHC
     LAVRPGRTLP EELVGSSKVI VYTGDLAAKR LGLSAPQAQE IFSSAAAIIH NGAEVSHMKS
     YHSLRPTNVD STRQLVELAL RSSIDSAVRT PAFHYVSTAG VGHLLGIPAF PEQSVSSSPP
     PVDGSDGYVA AKWASERILE QASERLGLPV FIHRPSNITG PDVGDRDIIH NVWRWSEVLR
     AVPDLVAAGA KGAFDFVGVE TCAKGITDTL FVQASAGHLA YIHQSGENVI PVEEFGECLQ
     RNGGADVELV PFDQWVDKAV QAGLDDLVAS FLRGTKGAFQ MPFLPKGLRQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024